Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells
Background: Up to 40% of women with ovarian cancer have short disease-free intervals due to molecular mechanisms of chemotherapy resistance. New therapeutic strategies are sought. Ovarian cancers are sensitive to radiochemotherapy. The taxane cabazitaxel (XRP6258, Jevtana) promotes tubulin assembly...
Main Authors: | Charles eKunos, Tammy eStefan, James William Jacobberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00226/full |
Similar Items
-
Critical appraisal of cabazitaxel in the management of advanced prostate cancer
by: Sumanta Kumar Pal, et al.
Published: (2010-12-01) -
Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
by: Nagavendra Kommineni, et al.
Published: (2019-03-01) -
Radiation quality, like art, consists in drawing the line somewhere
by: Charles eKunos, et al.
Published: (2013-07-01) -
Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
by: Amelia Barcellini, et al.
Published: (2022-12-01) -
Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted solutions in three infusion bags
by: D’Huart Elise, et al.
Published: (2023-07-01)